PCP acts primarily as an antagonist at which receptor?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the Certified Addictions Registered Nurse (CARN) Advanced Practice Test. Utilize flashcards and multiple-choice questions, complete with hints and explanations. Boost your readiness for the exam!

Multiple Choice

PCP acts primarily as an antagonist at which receptor?

Explanation:
PCP’s primary action is as a noncompetitive antagonist at NMDA receptors, the glutamate-activated ion channels in the brain. By blocking the NMDA channel, it disrupts excitatory signaling and calcium influx, which leads to the dissociative anesthesia and psychotomimetic effects PCP is known for. This mechanism explains its characteristic profile more than any direct action on dopamine D2, GABA-A, or 5-HT2 receptors. Dopamine changes can occur downstream, but they are not PCP’s defining target, and PCP does not act as a GABA-A agonist or primarily as a 5-HT2 antagonist.

PCP’s primary action is as a noncompetitive antagonist at NMDA receptors, the glutamate-activated ion channels in the brain. By blocking the NMDA channel, it disrupts excitatory signaling and calcium influx, which leads to the dissociative anesthesia and psychotomimetic effects PCP is known for. This mechanism explains its characteristic profile more than any direct action on dopamine D2, GABA-A, or 5-HT2 receptors. Dopamine changes can occur downstream, but they are not PCP’s defining target, and PCP does not act as a GABA-A agonist or primarily as a 5-HT2 antagonist.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy